Aperture Venture Partners is a New York-based venture capital firm that primarily invests in early-stage and venture capital opportunities within the healthcare industry. Their focus areas include medical devices, pharmaceuticals, healthcare IT/services, and diagnostics.
41% of their portfolio is in Healthcare. Average disclosed round size is $42.3M (across 17 rounds with reported amounts).
Portfolio
17
Fund Size
$500M
Top Stage
Series C
Last 12 Mo
3
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
17 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Tangible | Seed | $4.3M | Feb 2026 |
 Ex Nunc Intelligence | Pre-Seed | $2.1M | Jan 2026 |
 Neuros Medical | Series D | $56M | Jul 2025 |
| SShoulder Innovations | Series E | $40M | Mar 2025 |
| CCyder | Pre-Seed | $1.1M | Dec 2024 |
 Trustap | Unknown | $5.1M | Jul 2024 |
 Kayna | Pre-Seed | $1M | Sep 2023 |
 Pryon | Series D | $100M | Sep 2023 |
 Cortica, Inc. | Growth | $75M | Apr 2023 |
 XII Medical, Inc. | Series A | $30M | May 2022 |
| Cortica, Inc. | Series C | $60M | Jun 2021 |
 V-Wave Ltd. | Series C | $98M | Sep 2020 |
 Tarsus Pharmaceuticals | Series B | $60M | Jan 2020 |
 ShiraTronics, Inc. | Series A | $33M | Oct 2019 |
 Endotronix, Inc. | Series D | $45M | Sep 2018 |
 Otonomy, Inc. | Series C | $45.9M | Sep 2013 |
 PetDx | Series B | $62M | — |
Top Co-Investors
Longitude Capital2 shared
.406 Ventures2 shared
Deerfield2 shared
U.S. Venture Partners2 shared
Amzak Health2 shared
Osage University Partners2 shared
Sectoral Asset Management2 shared
Ajax Health2 shared
Middlegame Ventures2 shared
Silicon Valley Bank1 shared
Endeavour Vision1 shared
Pontifax1 shared
Pura Vida Investments1 shared
TriVentures1 shared
EQT Life Sciences1 shared
Gilde Healthcare1 shared
Gilmartin Capital1 shared
USVP1 shared
Optum Ventures1 shared
RA Capital Management1 shared
Last updated: 16 April 2026